Gene Ontology |
GO ID | Evidence Type | GO Description |
GO:0003073 |
ISS |
regulation of systemic arterial blood pressure |
GO:0003214 |
ISS |
cardiac left ventricle morphogenesis |
GO:0004672 |
IEA |
protein kinase activity |
GO:0004674 |
IDA |
protein serine/threonine kinase activity |
GO:0004713 |
IEA |
protein tyrosine kinase activity |
GO:0005515 |
IPI |
protein binding |
GO:0005524 |
IEA |
ATP binding |
GO:0005829 |
TAS |
cytosol |
GO:0005977 |
IEA |
glycogen metabolic process |
GO:0006349 |
IEA |
regulation of gene expression by genetic imprinting |
GO:0006468 |
IDA:IEA |
protein phosphorylation |
GO:0006987 |
TAS |
activation of signaling protein activity involved in unfolded protein response |
GO:0007173 |
TAS |
epidermal growth factor receptor signaling pathway |
GO:0007399 |
IEA |
nervous system development |
GO:0008286 |
ISS |
insulin receptor signaling pathway |
GO:0008543 |
TAS |
fibroblast growth factor receptor signaling pathway |
GO:0010800 |
IEA |
positive regulation of peptidyl-threonine phosphorylation |
GO:0010905 |
IC |
negative regulation of UDP-glucose catabolic process |
GO:0016055 |
IEA |
Wnt signaling pathway |
GO:0016477 |
IEA |
cell migration |
GO:0016772 |
IEA |
transferase activity, transferring phosphorus-containing groups |
GO:0030819 |
ISS |
positive regulation of cAMP biosynthetic process |
GO:0030877 |
TAS |
beta-catenin destruction complex |
GO:0030968 |
TAS |
endoplasmic reticulum unfolded protein response |
GO:0032007 |
ISS |
negative regulation of TOR signaling |
GO:0032869 |
IMP |
cellular response to insulin stimulus |
GO:0033138 |
IEA |
positive regulation of peptidyl-serine phosphorylation |
GO:0034236 |
IPI |
protein kinase A catalytic subunit binding |
GO:0036016 |
ISS |
cellular response to interleukin-3 |
GO:0038095 |
TAS |
Fc-epsilon receptor signaling pathway |
GO:0043161 |
ISS |
proteasome-mediated ubiquitin-dependent protein catabolic process |
GO:0044027 |
IEA |
hypermethylation of CpG island |
GO:0044267 |
TAS |
cellular protein metabolic process |
GO:0045087 |
TAS |
innate immune response |
GO:0045719 |
TAS |
negative regulation of glycogen biosynthetic process |
GO:0045732 |
NAS |
positive regulation of protein catabolic process |
GO:0045823 |
ISS |
positive regulation of heart contraction |
GO:0045944 |
IEA |
positive regulation of transcription from RNA polymerase II promoter |
GO:0046325 |
IMP |
negative regulation of glucose import |
GO:0046627 |
IMP |
negative regulation of insulin receptor signaling pathway |
GO:0048011 |
TAS |
neurotrophin TRK receptor signaling pathway |
GO:0048015 |
TAS |
phosphatidylinositol-mediated signaling |
GO:0050321 |
TAS |
tau-protein kinase activity |
GO:0051348 |
IMP |
negative regulation of transferase activity |
GO:0061052 |
ISS |
negative regulation of cell growth involved in cardiac muscle cell development |
GO:0071285 |
IEA |
cellular response to lithium ion |
GO:0071407 |
IEA |
cellular response to organic cyclic compound |
GO:0071879 |
ISS |
positive regulation of adrenergic receptor signaling pathway |
GO:0090090 |
TAS |
negative regulation of canonical Wnt signaling pathway |
GO:0097192 |
ISS |
extrinsic apoptotic signaling pathway in absence of ligand |
GO:1901030 |
ISS |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
GO:2000077 |
TAS |
negative regulation of type B pancreatic cell development |
GO:2000466 |
TAS |
negative regulation of glycogen (starch) synthase activity |
GO:2000467 |
ISS |
positive regulation of glycogen (starch) synthase activity |